Here, we found that knockdown of GRP78 by siRNA significantly attenuated TAC-induced cardiac hypertrophy and dysfunction compared with siRNA control (Figure 6), indicating that GRP78 promotes cardiac hypertrophic remodeling and HF. Here, HSPA5 is linked to cardiac hypertrophy.